Literature DB >> 10471053

Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.

S Aaltomaa1, P Lipponen, M Ala-Opas, M Eskelinen, K Syrjänen, V M Kosma.   

Abstract

We have studied 118 renal cell carcinomas to analyse the expressions of cyclins A and D1 and p21(waf1/cip1), and their relationship to clinical and histopathological parameters as well as to clinical outcome. Cyclins A and D1 and cyclin-dependent kinase inhibitor p21 (waf1/cip1) were not expressed in normal renal tissue. Staining signals of cyclin D1 and p21(waf1/cip1) were always nuclear but cyclin A was also expressed in the cytoplasm of the tumour cells. The mean (range) fractions of cyclin A, cyclin D1 and p21(waf1/cip1)-positive tumour cells were 2.2% (range 0-20%), 23.3% (range 0-90%) and 6.8% (range 0-70%) respectively. The expression of cyclin A was related to venous invasion, high nuclear grade, high mitotic rate, high Ki-67 and high PCNA expressions (P < or = 0.006 for all). The expression of cyclin D1 was linked with age over 65 years, low nuclear grade and high p53 expression (P < or = 0.05 for all). An inverse correlation was present between p21(waf1/cip1) and cyclin D1 (P = 0.011). Cyclin A predicted survival in the entire study group (P = 0.0014), in T1-4/N0-2/M0 (P = 0.0007) and in T1-2/N0/M0 tumours (P = 0.0007). Cyclin A was also a powerful predictor of disease-free survival in T1-4/N0/M0 (P = 0.0027) tumours (P = 0.0007). Cyclin D1 and p21(waf1/cip1) were not significantly related to survival or disease-free survival in any of the groups. In the entire material the independent prognostic factors were the presence of distant metastases (relative risk (RR) 5.16, P < 0.001), T category (RR 2.68, P < 0.001), Ki-67 expression (RR 1.02, P = 0.026) and cyclin A expression (RR 1.12, P = 0.001). The independent predictors in T1-4/N0/M0 tumours were T-category (RR 2.67, P = 0.001) and cyclin A (RR 1.21, P < 0.001), and in T1-2/N0/M0 tumours the only significant predictor was cyclin A (RR 1.19, P = 0.0002). In renal cell carcinoma, cyclin A is a powerful and independent prognostic factor in all clinical stages of the disease, whereas cyclin D1 and p21(waf1/cip1) have no prognostic value.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471053      PMCID: PMC2363145          DOI: 10.1038/sj.bjc.6690634

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma.

Authors:  R Paul; C M Ewing; J C Robinson; F F Marshall; K R Johnson; M J Wheelock; W B Isaacs
Journal:  Cancer Res       Date:  1997-07-01       Impact factor: 12.701

2.  A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens.

Authors:  M Nakamura; M Katano; K Fujimoto; T Morisaki
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

3.  Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.

Authors:  T Naka; N Toyota; T Kaneko; N Kaibara
Journal:  Anticancer Res       Date:  1998 Jan-Feb       Impact factor: 2.480

4.  Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression.

Authors:  W Yasui; Y Akama; H Yokozaki; S Semba; Y Kudo; F Shimamoto; E Tahara
Journal:  Pathol Int       Date:  1997-07       Impact factor: 2.534

5.  Cyclin D1 overexpression and prognosis in colorectal adenocarcinoma.

Authors:  K Maeda; Y Chung; S Kang; M Ogawa; N Onoda; Y Nishiguchi; T Ikehara; B Nakata; M Okuno; M Sowa
Journal:  Oncology       Date:  1998 Mar-Apr       Impact factor: 2.935

6.  Value of p53 expression, cellular proliferation, and DNA content as prognostic indicators in renal cell carcinoma.

Authors:  I Papadopoulos; P Rudolph; K Weichert-Jacobsen
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

7.  p53 protein in endometrial cancer is related to proliferative activity and prognosis but not to expression of p21 protein.

Authors:  J Backe; A M Gassel; K Hauber; S Krebs; J Bartek; H Caffier; H H Kreipe; H K Müller-Hermelink; J Dietl
Journal:  Int J Gynecol Pathol       Date:  1997-10       Impact factor: 2.762

8.  Is the expression of multidrug resistance gene product a prognostic indicator for the clinical outcome of patients with renal cancer?

Authors:  G Hofmockel; I D Bassukas; A Wittmann; J Dämmrich
Journal:  Br J Urol       Date:  1997-07

9.  Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.

Authors:  K Y Shin; G Kong; W S Kim; T Y Lee; Y N Woo; J D Lee
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma.

Authors:  T Ishikawa; M Furihata; Y Ohtsuki; H Murakami; A Inoue; S Ogoshi
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  20 in total

1.  A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.

Authors:  James R Lambert; Vikram J Eddy; Christian D Young; Kelly S Persons; Sibaji Sarkar; Julie A Kelly; Elizabeth Genova; M Scott Lucia; Douglas V Faller; Rahul Ray
Journal:  Cancer Prev Res (Phila)       Date:  2010-12

2.  Targeted therapy in renal cancer.

Authors:  Tanya B Dorff; Amir Goldkorn; David I Quinn
Journal:  Ther Adv Med Oncol       Date:  2009-11       Impact factor: 8.168

3.  Unreported intrinsic disorder in proteins: Disorder emergency room.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2015-04-22

4.  Cellular transcripts regulated during infections with Highly Pathogenic H5N1 Avian Influenza virus in 3 host systems.

Authors:  Vinod Rmt Balasubramaniam; Sharifah S Hassan; Abdul R Omar; Maizan Mohamed; Suriani M Noor; Ramlan Mohamed; Iekhsan Othman
Journal:  Virol J       Date:  2011-04-29       Impact factor: 4.099

5.  Cyclin A2, a novel regulator of EMT.

Authors:  Nawal Bendris; Caroline T Cheung; Hon Sing Leong; John D Lewis; Ann F Chambers; Jean Marie Blanchard; Bénédicte Lemmers
Journal:  Cell Mol Life Sci       Date:  2014-05-31       Impact factor: 9.261

6.  NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation.

Authors:  Amit Bera; Nandini Ghosh-Choudhury; Nirmalya Dey; Falguni Das; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  Cell Signal       Date:  2013-08-24       Impact factor: 4.315

7.  The prognostic value of cyclin D1 in renal cell carcinoma.

Authors:  M S Lima; R A Pereira; R S Costa; S Tucci; M Dantas; V F Muglia; R C Ravinal; G E Barros-Silva
Journal:  Int Urol Nephrol       Date:  2013-11-17       Impact factor: 2.370

8.  A novel function for Cyclin A2: control of cell invasion via RhoA signaling.

Authors:  Nikola Arsic; Nawal Bendris; Marion Peter; Christina Begon-Pescia; Cosette Rebouissou; Gilles Gadéa; Nathalie Bouquier; Frédéric Bibeau; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  J Cell Biol       Date:  2012-01-09       Impact factor: 10.539

9.  Galectin-3 and cyclin D1 expression in non-small cell lung cancer.

Authors:  Monika Kosacka; Paweł Piesiak; Aneta Kowal; Marcin Gołecki; Renata Jankowska
Journal:  J Exp Clin Cancer Res       Date:  2011-10-24

10.  Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray.

Authors:  Y Hedberg; B Ljungberg; G Roos; G Landberg
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.